billHR6199•Event Thursday, November 20, 2025Analyzed

Medical Nutrition Therapy Act of 2025

Neutral

Impact4/10

$LH UnitedHealth Group ($UNH)CVS Health ($CVS)Walmart ($WMT)$DG $KR Healthcare Consumer

Summary

The Medical Nutrition Therapy Act of 2025 (HR6199) is in the early stages of the legislative process, having been referred to two House committees. This bill aims to expand Medicare coverage for medical nutrition therapy to a wider range of chronic conditions and allow more healthcare professionals to make referrals, which would increase the total addressable market for nutrition-related services. While the bill does not appropriate funds, its passage would create new revenue streams for healthcare providers and retailers with nutrition programs.

Key Takeaways

1.HR6199 expands Medicare coverage for medical nutrition therapy to more chronic conditions and referral sources.
2.The bill is in early legislative stages, referred to two House committees, with a companion Senate bill (S3934).
3.No direct funding is authorized or appropriated by the bill; it expands services covered under existing Medicare reimbursement.
4.Healthcare providers and retailers with nutrition programs stand to benefit from an increased total addressable market.

Market Implications

The Medical Nutrition Therapy Act of 2025, if enacted, would structurally increase the demand for medical nutrition therapy services by expanding Medicare coverage. This would benefit companies like Labcorp Holdings Inc. ($LH) and UnitedHealth Group Incorporated ($UNH) through increased service utilization and claims processing. Retailers such as CVS Health Corporation ($CVS), Walmart Inc. ($WMT), Dollar General Corporation ($DG), and The Kroger Co. ($KR) could see new revenue opportunities by offering or expanding nutrition services to a larger Medicare beneficiary base. While the bill is in its early stages and does not currently impact market prices, its potential passage represents a long-term growth driver for these sectors. Recent market movements for these tickers, such as $UNH's 7.48% increase over 7 days to $281.36 and $LH's 4.12% increase to $274.46, reflect broader market dynamics and not direct influence from this specific bill.

Full Analysis

The Medical Nutrition Therapy Act of 2025 (HR6199) was introduced in the House on November 20, 2025, and subsequently referred to the Committee on Energy and Commerce and the Committee on Ways and Means. This bill seeks to amend title XVIII of the Social Security Act to expand Medicare coverage for medical nutrition therapy services beyond diabetes and kidney disease to include conditions such as obesity, eating disorders, cancer, and HIV/AIDS. It also broadens the types of healthcare professionals, including physician assistants and nurse practitioners, who can refer patients for these services. This bill does not authorize or appropriate a specific dollar amount. Instead, it expands the scope of services covered by Medicare, which would lead to an increase in the utilization of medical nutrition therapy. The funding mechanism would be through existing Medicare Part B reimbursement structures for covered services. This means that while no new direct government spending is mandated by the bill itself, the expansion of covered services would result in increased payments to providers for these services under the Medicare program. Structural winners from the potential passage of this bill include healthcare providers offering nutrition services, such as Labcorp Holdings Inc. ($LH) through its diagnostic and health services, and UnitedHealth Group Incorporated ($UNH) as a major health insurer that would process claims for these expanded services. Retailers with health and wellness programs or clinics, such as CVS Health Corporation ($CVS), Walmart Inc. ($WMT), Dollar General Corporation ($DG), and The Kroger Co. ($KR), could also benefit by integrating or expanding nutrition services to Medicare beneficiaries. Omnicell, Inc. ($OMCL) is less directly impacted as its primary business is medication management and supply chain automation, not direct nutrition therapy. Looking at recent market data, over the past 7 days, $LH has increased by 4.12% to $274.46, $UNH by 7.48% to $281.36, and $CVS by 4.48% to $73.28. Walmart ($WMT) has seen a 2.66% increase to $126.79, and Dollar General ($DG) a 6.08% increase to $125.01. Kroger ($KR) has decreased by 0.94% to $73.03. These movements are part of broader market trends and are not directly attributable to HR6199 given its early legislative stage. The bill is currently in committee, and its legislative path involves committee consideration, potential amendments, and votes in both the House and Senate. A companion bill, S3934, has been introduced in the Senate, indicating bipartisan and bicameral interest in the issue, which could increase its chances of eventual passage.